We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+3.39%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$1.22B
AUM Growth
+$236M
(+24%)
Cap. Flow
+$242M
Cap. Flow
% of AUM
19.95%
Top 10 Holdings %
Top 10 Hldgs %
10.08%
Holding
636
New
201
Increased
78
Reduced
62
Closed
295
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$14.2M |
| 2 |
Devon Energy
DVN
|
+$12.8M |
| 3 |
Ulta Beauty
ULTA
|
+$12.7M |
| 4 |
Goldman Sachs
GS
|
+$12.7M |
| 5 |
Monster Beverage
MNST
|
+$11.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nutanix
NTNX
|
+$10.6M |
| 2 |
Southwest Airlines
LUV
|
+$10.2M |
| 3 |
ExxonMobil
XOM
|
+$10.2M |
| 4 |
Costco
COST
|
+$9.96M |
| 5 |
PPL
PPL Corp
PPL
|
+$9.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 21.31% |
| 2 | Technology | 17.79% |
| 3 | Financials | 12.54% |
| 4 | Healthcare | 11.75% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
ICU Medical
ICUI
$4.16B
| $1.54M | 0.13% |
+6,100
| New | +$1.43M |
|
202
DexCom
DXCM
$29B
| $1.5M | 0.12% |
+81,052
| New | +$1.2M |
|
|
SINA
203
DELISTED
Sina Corp
SINA
| $1.48M | 0.12% |
14,196
+5,800
| +69% | +$665K |
|
|
MON
204
DELISTED
Monsanto Co
MON
| $1.48M | 0.12% |
12,681
-54,000
| -81% | -$6.5M |
|
205
RPC Inc
RES
$1.13B
| $1.48M | 0.12% |
+82,055
| New | +$1.72M |
|
206
MSCI
MSCI
$42.4B
| $1.44M | 0.12% |
9,599
-7,700
| -45% | -$1.1M |
|
|
MLNX
207
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $1.39M | 0.11% |
19,100
+12,500
| +189% | +$842K |
|
208
Valero Energy
VLO
$89.5B
| $1.38M | 0.11% |
+14,833
| New | +$1.38M |
|
209
ATI
ATI
$24.3B
| $1.37M | 0.11% |
57,859
+48,900
| +546% | +$1.31M |
|
|
BNY
210
Bank of New York Mellon
BNY
$103B
| $1.36M | 0.11% |
26,337
-1,900
| -7% | -$106K |
|
211
HealthEquity
HQY
$8.71B
| $1.36M | 0.11% |
+22,400
| New | +$1.21M |
|
212
Philip Morris
PM
$309B
| $1.34M | 0.11% |
+13,479
| New | +$1.4M |
|
213
Target
TGT
$66.3B
| $1.33M | 0.11% |
+19,170
| New | +$1.4M |
|
214
Bank of America
BAC
$429B
| $1.31M | 0.11% |
+43,815
| New | +$1.38M |
|
|
DISCK
215
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $1.31M | 0.11% |
+67,313
| New | +$1.51M |
|
216
Mohawk Industries
MHK
$6.91B
| $1.3M | 0.11% |
+5,600
| New | +$1.44M |
|
217
3D Systems Corp
DDD
$405M
| $1.24M | 0.1% |
+106,602
| New | +$1.14M |
|
218
Marriott International
MAR
$100B
| $1.21M | 0.1% |
+8,901
| New | +$1.25M |
|
|
SGMO
219
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.2M | 0.1% |
63,289
+41,089
| +185% | +$878K |
|
|
MASI
220
DELISTED
Masimo
MASI
| $1.18M | 0.1% |
+13,408
| New | +$1.17M |
|
221
Cencora
COR
$62B
| $1.15M | 0.09% |
+13,326
| New | +$1.28M |
|
|
OCLR
222
DELISTED
Oclaro Inc.
OCLR
| $1.15M | 0.09% |
+119,981
| New | +$901K |
|
|
BID
223
DELISTED
Sotheby's
BID
| $1.11M | 0.09% |
+21,600
| New | +$1.1M |
|
224
Baker Hughes
BKR
$58.3B
| $1.04M | 0.09% |
37,600
-37,300
| -50% | -$1.14M |
|
|
FOLD
225
DELISTED
Amicus Therapeutics
FOLD
| $1M | 0.08% |
66,755
-68,345
| -51% | -$1.04M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Seven Eight Capital held 636 positions worth $1.22B, up 24% from $979M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Seven Eight Capital deployed $242M of net new capital in Q1 2018, opening 201 new positions and adding to 78 existing holdings. Its largest new stake was AbbVie: 129,358 shares worth $12.2M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Nutanix, an estimated $10.6M trimmed.
- Seven Eight Capital's largest Q1 2018 buy was AbbVie: 129,358 shares worth $12.2M.
- Seven Eight Capital added most to Ulta Beauty in Q1 2018, an estimated $12.7M increase.
- Seven Eight Capital's biggest Q1 2018 reduction was Nutanix, cutting an estimated $10.6M.
- Seven Eight Capital fully exited Southwest Airlines in Q1 2018, selling an estimated $10.2M.
- Seven Eight Capital's ten largest holdings make up 10% of its $1.22B portfolio in Q1 2018.
- Seven Eight Capital opened 201 new positions and closed 295 in Q1 2018.
- Seven Eight Capital's portfolio value rose 24% quarter-over-quarter to $1.22B.
Based on Seven Eight Capital's 13F filing for Q1 2018, filed 14 May 2018.